JOHN PAULO BAUTISTA: Open Payments
NPI 1366907602 · TEMPE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,755 in 99 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $1,691 · 2025 $2,755
Food & beverage: $2,557Education: $198
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $604 |
| Regeneron Healthcare Solutions, Inc. | 11 | $274 |
| GlaxoSmithKline, LLC. | 14 | $274 |
| Actelion Pharmaceuticals US, Inc. | 5 | $237 |
| GENZYME CORPORATION | 13 | $208 |
| Grifols USA, LLC | 4 | $188 |
| Verona Pharma, Inc. | 6 | $171 |
| Axsome Therapeutics, Inc. | 6 | $162 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $102 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
Products named: DUPIXENT, FASENRA, NUCALA, Prolastin-C Liquid, Ohtuvayre, Sunosi, UPTRAVI, BREZTRI.
Industry payments across AZ — which companies pay providers there.
